Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Jun, Frost, Freddy, Nazareth, Dilip, Walshaw, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920311/
https://www.ncbi.nlm.nih.gov/pubmed/29770214
http://dx.doi.org/10.12688/f1000research.14505.1
_version_ 1783317807701688320
author Yong, Jun
Frost, Freddy
Nazareth, Dilip
Walshaw, Martin
author_facet Yong, Jun
Frost, Freddy
Nazareth, Dilip
Walshaw, Martin
author_sort Yong, Jun
collection PubMed
description Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation.
format Online
Article
Text
id pubmed-5920311
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-59203112018-05-15 Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis Yong, Jun Frost, Freddy Nazareth, Dilip Walshaw, Martin F1000Res Case Report Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation. F1000 Research Limited 2018-04-18 /pmc/articles/PMC5920311/ /pubmed/29770214 http://dx.doi.org/10.12688/f1000research.14505.1 Text en Copyright: © 2018 Yong J et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yong, Jun
Frost, Freddy
Nazareth, Dilip
Walshaw, Martin
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title_full Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title_fullStr Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title_full_unstemmed Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title_short Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
title_sort case report: haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920311/
https://www.ncbi.nlm.nih.gov/pubmed/29770214
http://dx.doi.org/10.12688/f1000research.14505.1
work_keys_str_mv AT yongjun casereporthaemolyticanaemiawithceftazidimeuseinapatientwithcysticfibrosis
AT frostfreddy casereporthaemolyticanaemiawithceftazidimeuseinapatientwithcysticfibrosis
AT nazarethdilip casereporthaemolyticanaemiawithceftazidimeuseinapatientwithcysticfibrosis
AT walshawmartin casereporthaemolyticanaemiawithceftazidimeuseinapatientwithcysticfibrosis

Ejemplares similares